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Objective: Patch closure after carotid endarterectomy (CEA) improves clinical outcome compared with primary closure.
Whether there are differences in outcome between various patch materials is still not clear. The objective of this
retrospective study was to investigate whether a relationship exists between the patch type and the number of
microemboli as registered during CEA by transcranial Doppler imaging, the clinical outcome (transient ischemic attack
and cerebrovascular accident), and the occurrence of restenosis.
Methods:We included 319 patients who underwent CEA. Intraoperative microembolus registration was performed in 205
procedures. Microembolization was recorded during four different periods: dissection, shunting, clamp release, and
wound closure. The decision to perform primary closure or to use a patch for the closure of the arteriotomy was made by
the surgeon, and Dacron patches were used when venous material was insufficient. Cerebral events were recorded within
the first month after CEA, and duplex scanning was performed at 3 months (n  319) and 1 year (n  166) after CEA.
A diameter reduction of more than 70% was defined as restenosis.
Results: Primary, venous, and Dacron patch closures were performed in 83 (26.0%), 171 (53.6%), and 65 (20.4%)
patients, respectively. Primary closure was significantly related to sex (Dacron patch, 35 men and 30 women; venous
patch, 108 men and 63 women; primary closure, 72 men and 11 women; P < .001). The occurrence of microemboli
during wound closure was also related to sex (women, 2.5  0.6; men, 1.0  0.2; P  .01). Additionally, during clamp
release, Dacron patches were associated with significantly more microemboli than venous patches (11.1  3.4 vs 4.0 
0.9; P < .01), and this difference was also noted during wound closure (3.1  0.9 vs 1.4  0.4; P < .05). Transient
ischemic attacks and minor strokes after CEA occurred in 5 (2.4%) of 205 and 6 (2.9%) of 205 procedures, respectively,
and the degree of microembolization during dissection was related to adverse cerebral events (P .003). In contrast, the
type of closure was not related to immediate clinical adverse events. However, primary closure and Dacron patches were
associated with an increase in the restenosis rate compared with venous patches: after 400 days, the restenosis rate for
Primary closure was 11%, Dacron patch 16%, and venous patch 7% (P  .05; Kaplan-Meier estimates).
Conclusions: Microemboli are more prevalent during clamp releases and wound closure when Dacron patches are used.
Additionally, the observed differences in embolization noted by patch type were mainly evident in women. However, the
use of Dacron patches was not related to immediate ischemic cerebral events but was associated with a higher restenosis
rate compared with venous patch closure. This suggests that venous patch closure may be preferred for CEA. (J Vasc
Surg 2005;42:1082–8.)A recent systematic review concerning the type of arte-
riotomy closure in carotid endarterectomy (CEA) showed
the benefits of patching over primary closure.1 However,
sufficient data are lacking to allow firm conclusions to be
drawn regarding differences between various patch materi-
als used for carotid closure. Synthetic patches are believed
to be more thrombogenic than venous patches and may
therefore theoretically produce emboli that could result in
associated adverse cerebral events.
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1082During CEA, transcranial Doppler (TCD) registration
of the middle cerebral artery provides online surveillance of
hemodynamic changes and the passage of cerebral micro-
emboli,2-4 and the occurrence of microemboli, recorded by
TCDduring CEA, has been related to the risk of immediate
adverse cerebral events.3,5,6 Therefore, different patch ma-
terials could influence the outcome of the operation as a
result of differences in the number of microemboli.7 Fur-
thermore, several studies suggest that the type of patch
used for closure of the carotid artery is also associated with
late restenosis.1,7-12 The objective of this study was to
investigate whether a relationship exists between the type of
patch used, the number of TCD-detected microemboli
during CEA, immediate adverse cerebral events, and reste-
nosis.
METHODS
Patients. This study is part of ATHERO-EXPRESS,
which is an ongoing prospective longitudinal study with
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characteristics in long-term outcome in patients with ca-
rotid atherosclerosis. The design of the study has been
described previously,13 and ATHERO-EXPRESS is cur-
rently being executed in two Dutch hospitals. Recruitment
of patients started in April 2002 and will continue until at
least 1000 patients have been included. All patients receiv-
ing operative treatment for carotid stenosis in the vascular
surgery departments of the participating centers are en-
rolled. Patients can be symptomatic or asymptomatic, and
surgery is indicated when color Doppler–assisted duplex
ultrasound investigation, magnetic resonance angiography,
computed tomographic angiography, or angiography re-
veals a diameter reduction of more than 70% on at least one
side. In asymptomatic patients with stenosis greater than
70%, the indication for surgery is also based on recommen-
dations published by the Asymptomatic Carotid Surgery
Trial.14 At baseline, clinical data from patients’ records, a
questionnaire about medical history, blood samples, and
atherosclerotic tissue harvested during CEA are collected.
In this study, we analyzed 319 patients with 3 months and
1 year (n  166) of follow-up after CEA.
Carotid endarterectomy. Preoperative antiplatelet ther-
apywas continued during the operation. All patients under-
went operation under general anesthesia, and TCD and
electroencephalographicmonitoringwere used. Shuntingwas
performed selectively on the basis of electroencephalogram
and TCD criteria, as described in previous articles. 15,16 Before
cross clamping, a bolus of heparin (5000 IU) was given
intravenously. All endarterectomies were performed open,
with dissection of the bifurcation into the internal and
external carotid arteries. Patch closure was generally the
preferred technique, especially when the lumen of the
internal carotid artery was less than 3 mm or when a shunt
had to be used. Venous patches were preferred and were
usually obtained from the saphenous vein at the ankle or
inguinal level when the vascular surgeon favored patch
closure. A Dacron patch (Intervascular; DuPont, Wilming-
ton, Del) was used only when venous material was not
available or when the venous material harvested was per-
ceived to be of insufficient strength. The medical ethics
committees of the participating hospitals approved the
study.
TCD monitoring. Because of logistic reasons, it was
not always possible to record emboli to the highest stan-
dard during TCD recording. Therefore, we reported the
TCD registrations of 205 of 319 patients. The methods
of TCD monitoring have been reported previously.15,16
Briefly, the Doppler spectra were observed online in the
operating room by an experienced sonographer. Doppler
signals were recorded, and high-intensity transient signals
indicating microemboli were identified. All microembolic
events were counted and recorded during four different
phases of the surgical procedure: (1) dissection (all micro-
embolic events from skin incision until cross clamping), (2)
shunting (if a shunt was used; microemboli that occurred
from the introduction to the removal of the shunt), (3)
clamp release (the first 10 seconds after restoration of theflow through the carotid arteries), and (4) wound closure
(after 10 seconds of flow restoration until the end of the
operation). Observed microemboli that could not be
counted separately during one heartbeat were entitled
shower microemboli. A shower of microemboli was given the
arbitrary number of 10 microemboli, which is the maxi-
mum number of microemboli that can be discriminated
during 1 heartbeat.
Clinical events. Patients’ hospital records were re-
viewed to obtain information concerning clinical events. A
neurologist was routinely consulted for all patients before
surgery and at the third day after operation. New neuro-
logic symptoms or worsening of existing symptoms that
persisted for longer than 24 hours was regarded as a stroke,
and strokes were classified according to the modified
Rankin Scale.17 New neurologic symptoms persisting less
than 24 hours were regarded as transient ischemic attacks.
Neurologic events were termed immediate adverse ischemic
cerebral events when they were diagnosed during the post-
operative period or when a readmission occurred for this
reason within 1 month after the operation.
Restenosis and duplex criteria. Determination of the
degree of recurrent stenosis during follow-up was based on
duplex ultrasonographic18 follow-up at 3 months (n 
319) and 1 or 2 years (n 166) after CEA. Restenosis was
defined as greater than 70% stenosis of the endarterectomy
area. Duplex criteria for restenosis are a combination of
peak systolic velocity greater than 125 cm/s and a gamma
(the ratio between peak systolic velocity in the stenotic area
and end diastolic velocity in distal common carotid artery)
greater than 12.
Data analysis. Microembolic data in tables are pre-
sented as mean  SEM. We used nonparametric tests for
continuous variables (Mann-Whitney test and Kruskal-
Wallis test) and 2 and Fisher exact tests for categorical
variables. When significant differences were found with the
Kruskal-Wallis test, the Dunn post hoc test was applied for
their possible relationship with microemboli. Kaplan-Meier
survival tables were used to assess differences in restenosis
rates among groups over time. Significance was calculated
with the log-rank test. All variables as displayed in the
baseline table were tested for their possible relationship
with restenosis and microemboli. P values of .05 were
considered statistically significant.
RESULTS
Primary, venous, and Dacron patch closures were per-
formed in 83 (26.0%), 171 (53.6%), and 65 (20.4%) pa-
tients, respectively. Table I presents the baseline patient
characteristics. Sex, smoking habits, and age differed signif-
icantly among groups. Additionally, closure type was re-
lated to sex; primary closure was significantly less common
in women (Dacron patch, 35 men and 30 women; venous
patch, 108 men and 63 women; and primary closure, 72
men and 11 women; P  .001).
Dacron patch use was associated with significantly
more microemboli compared with venous patches and
primary closure during the clamp-release phase and the
ngiopl
ant.
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exclude confounding of smoking, age, and sex, the analyses
were repeated for these variables. Smoking and age were
not related to an increased number of microemboli during
clamp release and wound closure (P  .4/P  .9 and P 
.9/P  .8). In contrast, women had more microemboli
observed during wound closure (P  .01; Table III).
Additionally, the significant relationship between the type
of patch used and the presence of microemboli was most
evident for women (Table II), so that in women, there was
clearly an increased number of recorded microemboli dur-
ing clamp release and wound closure when Dacron patches
were used. No such relationship was seen in men.
Adverse ischemic cerebral events (1 month after
CEA) occurred in 2.4% (transient ischemic attack) and
2.9% (minor strokes) of cases. These events were signifi-
cantly associated with microemboli during dissection but
not during shunting, clamp release, and wound closure
(Table IV; P  .003). Furthermore, a relationship between
patch use and immediate clinical adverse events was not
observed (Dacron patch, two events; vein patch, four
events; and primary closure, five events; P  .5).
Dacron patches were associated with an increased re-
Table I. Baseline patient characteristics
Variable Dacron patch
Male sex 54% (35/65) 6
Age, y, median (range) 67 (45-87)
Current smoker 18% (10/57) 3
Diabetes 18% (10/57) 1
Dyslipidemia 65% (36/55) 6
Symptoms 19 7
Left side operated on 70% (42/60) 5
Mean body mass index (kg/m2) 46% (30/65)
Myocardial infarction ever 27 1
Statin use 15% (9/59) 6
Angina pectoris ever 72% (46/64) 4
High blood pressure 33% (21/63) 6
CABG or coronary stent in the past 66% (39/59) 2
Peripheral vascular intervention in
the past (PTA/stent or bypass)
17% (11/63)
29% (18/63) 1
Antiplatelet or anticoagulant therapy 95% (58/61) 9
CABG, Coronary artery bypass grafting; PTA, percutaneous transluminal a
Table II. Patch and TCD-detected microemboli
Phase of CEA Dacron Vein Primary
Clamp release
All patients 11.1 (3.4) 4.0 (0.9) 9.8 (3.5
Male 9.8 (4.2) 4.7 (1.3) 9.9 (4.1
Female 13.7 (6.0) 2.8 (0.8) 9.1 (5.7
Wound closure
All patients 3.1 (0.9) 1.4 (0.4) 0.7 (0.2
Male 1.3 (0.5) 1.0 (0.4) 0.8 (0.3
Female 6.7 (2.1) 2.0 (0.7) 0.2 (0.1
Data are presented as mean (SEM).
TCD, Transcranial Doppler; CEA, carotid endarterectomy; NS, not significstenosis rate compared with venous patches: after 400 days,Dacron patch 16%, primary closure 11%, and venous patch
7% (log-rank test; P  .05; Fig 2). To exclude confounding
for smoking, age, and sex, analyses of these results were
repeated. Restenosis was equally distributed among smok-
ers and nonsmokers and categorized age groups. In con-
trast, women had an increased rate of restenosis when a
Dacron patch or primary closure was used (compared with
vein patching), whereas men showed an increased resteno-
sis rate for primary closure (nonsignificant for women or
men separately; log-rank test; P  .12 and P  .16; signif-
icant for men compared with women; P .02). All patients
but one who developed restenosis were asymptomatic.
Four of the patients with restenosis were treated with
carotid artery stent placement (including the symptomatic
patient), and one patient underwent CEA.
DISCUSSION
Carotid artery stenosis is a common presentation of
atherosclerotic disease.19 A total of 9% to 12% of patients
with known atherosclerotic disease have high-grade carotid
artery stenosis.20 CEA is a widely accepted method of
treating patients with significant carotid artery stenosis, and
prevention of perioperative adverse cerebral outcome and
n patch Primary Overall P value
108/171) 87% (72/83) 215/319 .001
40-84) 70 (55-85) 68 (40-87) .004
51/157) 18% (14/80) 75/294 .013
29/155) 19% (15/78) 54/290 .9
97/154) 55% (42/76) 175/28522 .4
126/165) 73% (59/81) 7/306 .6
91/171) 57% (47/83) 168/319 .4
26 27 26 .8
28/153) 28% (22/80) 59/292 .14
113/170) 61% (51/83) 210/317 .4
64/162) 41% (33/81) 118/306 .6
102/152) 64% (49/77) 190/288 .9
33/167) 27% (22/82) 66/312 .3
18% (15/82)
31/167) 64/312 .4
147/160) 92% (73/79) 278/300 .7
asty.
P value:
Dacron vs vein
P value:
primary vs vein
P value:
Dacron vs primary
.01 NS .05
NS NS NS
.01 NS NS
.05 NS .01
NS NS .08
.05 NS .01Vei
3% (
66 (
2% (
9% (
3% (
6% (
3% (
8% (
6% (
0% (
7% (
0% (
9% (
2% ()
)
)
)
)
)reduction of restenosis could improve long-term results
EA, C
JOURNAL OF VASCULAR SURGERY
Volume 42, Number 6 Verhoeven et al 1085after CEA. Direct outcome of CEA is related to preopera-
tive, intraoperative, and postoperative recorded microem-
boli.5,21,22 Additionally, as demonstrated here, microem-
boli during CEA occur variably throughout the procedure
and are related to sex and the type of closure used for
carotid reconstruction.
Because TCD is based on ultrasonography, it is not
possible to discriminate among different kinds of emboli
(particles of the plaque, thromboemboli, and gaseous em-
boli). We assume that microemboli during dissection are
mainly plaque particles and are thus associated with plaque
characteristics. In contrast, during wound closure, micro-
emboli are likely mainly thromboembolic, whereas during
clamp release, microemboli are likely to be gaseous.5 For
this reason, we divided embolic events during CEA into the
aforementioned categories.
The main findings of this study are as follows: (1)
Fig 1. Relationship between microemboli recorded dur
patches and primary closure. The Dacron patch was re
release and wound closure. Bars indicate median (for ve
during wound closure). Please note the y-axis scaling. C
Table III. Sex and microemboli
Phase of CEA Male Female P value
Dissection 1.4 (0.5) 0.8 (0.2) .87
Shunting 3.9 (0.9) 7.1 (3.2) .60
Clamp release 7.7 (1.8) 6.2 (1.6) .76
Wound closure 1.0 (0.2) 2.5 (0.6) .01
Data are presented as mean (SEM).
CEA, Carotid endarterectomy.Dacron patches are associated with significantly more mi-croemboli during clamp release and wound closure com-
pared with venous patch closure and primary closure, espe-
cially in women; (2) there is a relationship between female
sex and patch use, as well as with embolization and reste-
nosis; (3) the different types of arterial closure were not
associated with differences in adverse cerebral events before
1 month; (4) adverse cerebral events were associated with
more microemboli during the dissection phase but not
during shunting, clamp release, or wound closure; and (5)
venous patch use was associated with a decreased long-term
restenosis rate.
Embolism is the principal cause of cerebrovascular
complications from CEA.2 Prevention of embolic events
should contribute to a decrease in adverse cerebral events.
Not only emboli occurring during dissection of the athero-
lamp release and wound closure for the different kind of
to an increased number of microemboli during clamp
patch during clamp release and also for primary closure
arotid endarterectomy.
Table IV. Microemboli in patients with and without
adverse events at 2 weeks
Phase of CEA Stroke and TIA No event P value
Dissection 6.9 (5.3) 1.1 (0.3) .003
Shunting 4.4 (1.8) 5.3 (1.3) .8
Clamp release 15.1 (9.0) 6.6 (1.3) .9
Wound closure 1.3 (0.9) 1.5 (0.30) .9
Data are presented as mean (SEM).
CEA, Carotid endarterectomy.ing c
lated
noussclerotic plaque are associated with an increased risk of
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curves and estimates are presented for males and females combined (A), for males (B), and for females separately (C).
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surgery and during closure of the vessel are also related with
adverse outcome.5,6 The occurrence of emboli may be in-
fluenced by the closure technique used, so that the closure
technique with less risk of embolism should be preferable.
Probably because of the dividing of microemboli in the
aforementioned categories, we were able to relate micro-
emboli during wound closure and clamp release to Dacron
patches. This relationship was suggested by other authors,
but until now no statistical differences have been observed
between the different kinds of patch materials and the
occurrence of microemboli.7 The newly described relation-
ship between Dacron patching and the occurrence of mi-
croemboli could be explained by the thrombogenic charac-
teristics of this material, as described in earlier studies. 23,24
However, neither these studies nor the current one pro-
vides a final answer to the question of whether the cause is
mainly thromboembolic or gaseous or a combination of
both.
Women have been shown to have an increased number
of microemboli recorded after CEA.6,25 Hayes et al25 re-
lated this increased number of microemboli to the in-
creased risk for stroke in women after CEA, as published by
the European Carotid Surgery Trial and the North Ameri-
can Symptomatic Carotid Endarterectomy Trial Collabora-
tors.26,27 Our findings strengthen this hypothesis. The
increase of microemboli in female patients might be due to
an increased thromboembolic potential in women; this
could be related to the influence of estrogen and progestin.
The influence of these hormones on the risk for venous
thrombosis has been documented.28 Reiner et al29 also
showed an increased risk for stroke in young women with
genetic variants of platelet glycoprotein receptors.
We did not observe a relationship between immediate
ischemic cerebral events and the type of patch being used. A
recent review1 suggested such a relationship; therefore, the
small number of patients with adverse outcomes in our
study could explain our findings. In contrast, we did find a
relationship between ischemic events and an increased
number of microemboli during the dissection phase of the
operation. This was also described in a previous article, but
that study also showed a positive relationship between
emboli during wound closure and outcome, and we were
unable to reproduce this result in the current study.5 This
may also have been caused by the small number of patients
with adverse outcomes in our study.
Primary closure and Dacron patch closure were associ-
ated with an increased restenosis rate, and sex seemed to
modify this outcome strongly. This difference between the
sexes might be important and could influence conclusions
based on three recently published studies, in which Dacron
patch closure was recommended compared with primary
closure, but in which sex was not taken into account.9,30,31
The increased percentage of restenosis for Dacron patches
and primary closures could probably be explained by differ-
ent kinds of arterial remodeling and intimal hyperplasia. In
the literature, two types of remodeling are described: in-
ward remodeling, with a consistent outer diameter of thevessel and increasing neointima leading to restenosis, and
outward remodeling, with an increase of outer diameter
and an increase of neointima but a consistent luminal
area.32 The difference between restenosis after primary clo-
sure and venous patching is probably based on the difference
in luminal area and, thereby, differences in remodeling mech-
anisms. The difference in restenosis rates between Dacron
patches and venous patches could be explained by the fact that
prosthetic grafts lack endothelium. These prosthetic grafts
are covered with neointima consisting of fibroblasts and
fibrous matrix, which is known to induce intima hyperpla-
sia. Finally, the luminal areas between men and women are
also different, and this may contribute to the difference in
restenosis rates. The consequences of restenosis after CEA
are, however, still uncertain.
Limitations. Because this study was retrospective and
randomization between patchmaterials was not performed,
it is conceivable that there are differences in patient charac-
teristics among the groups and that a selection bias led to
the use of Dacron patches in patients with more severe
disease. However, we studied these characteristics and
could not identify such a difference. Additionally, the study
was limited by the number of patients with TCD registra-
tion in which microemboli were divided into the different
phases of CEA, as described previously in this article, and
this study did not deal with post-CEA microembolic re-
cordings. Finally, our long-term follow-up was limited.
However, the patients will be monitored, and data will
become available in the future.
Conclusions. On the basis of our results, avoiding
Dacron patches used for closure of the CEA is defendable.
Not only was an increased number of microemboli related
to Dacron patches, but restenosis was related to Dacron
patch closure as well. Thus, venous patch closure and primary
closure (in men) may be the preferred techniques.
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